NovaPump GmbH, a Jena, Germany-based heart technology firm, has completed a first round of financing with High-Tech Gründerfonds.
The amount of the deal was not disclosed.
The company intends to use the financing for the development of a catheter-based procedure for right heart and biventricular support that aims to achieve a higher pumping volume during the treatment of acute care cases.
Founded in mid-2012 by cardiologist Dr. Markus Ferrari and led by Managing Director Ronald Reich, NovaPump develops a percutaneous heart support procedure that can be used on either ventricle. The company will work on this project with partners from the world of medical technology including an experienced catheter manufacturer, a test laboratory for medical products as well as research institutions including Jena University Hospital’s Clinic for Internal Medicine and the Fraunhofer Institute for Applied Optics and Precision Engineering.
FinSMEs
01/08/2013